Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A software revision label on the page was updated from v3.6.4 to v3.6.5. This reflects a version bump and does not modify the study information or functionality visible to users.
    Difference
    0.1%
    Check dated 2026-08-10T13:28:40.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision tag `Revision: v3.6.4` was added, replacing the previous `Revision: v3.6.3`. This indicates an update to the page's build or versioning metadata without modifying the study details presented.
    Difference
    0.1%
    Check dated 2026-07-27T05:52:21.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a new version of the page template or system.
    Difference
    0.1%
    Check dated 2026-07-05T04:47:09.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A newer revision tag (v3.6.2) replaces the previous v3.6.0, indicating an updated version of the page documentation.
    Difference
    0.1%
    Check dated 2026-06-27T23:58:52.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', clarifying current availability. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision note to v3.6.0, along with a minor formatting tweak to the Intervention/Treatment label.
    Difference
    0.5%
    Check dated 2026-06-13T17:49:22.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The page now shows an updated revision label (v3.5.5) replacing the previous v3.5.4. This indicates a recent site or content update applied to the page.
    Difference
    0.1%
    Check dated 2026-06-06T14:08:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.